Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value: $229M (100.0% shares, 0.0% debt)

Holdings (38)

CI CIGNA CORP NEW 9.7%
Value $22.19M Shares 138,000 Est. Cost $179.63 Unrealized -7.0%
HANGER INC 7.8%
Value $17.78M Shares 933,548 Est. Cost $20.83 Unrealized
ZBH ZIMMER BIOMET HLDGS INC 6.9%
Value $15.77M Shares 123,500 Est. Cost $109.33 Unrealized -1.7%
REATA PHARMACEUTICALS INC 6.6%
Value $15.02M Shares 175,700 Est. Cost $46.26 Unrealized
BMY BRISTOL MYERS SQUIBB CO 5.9%
Value $13.5M Shares 283,000 Est. Cost $38.30 Unrealized 0.0%
ARENA PHARMACEUTICALS INC 5.0%
Value $11.32M Shares 252,500 Est. Cost $42.17 Unrealized
WELLCARE HEALTH PLANS INC 4.8%
Value $10.98M Shares 40,700 Est. Cost $236.10 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 3.8%
Value $8.721M Shares 917,080 Est. Cost $11.58 Unrealized -16.1%
ALBIREO PHARMA INC 3.8%
Value $8.691M Shares 269,836 Est. Cost $29.61 Unrealized
NEVRO CORP 3.5%
Value $8.049M Shares 128,765 Est. Cost $62.51 Unrealized
ASGN ASGN INC 3.0%
Value $6.928M Shares 109,116 Est. Cost $64.66 Unrealized -3.3%
ASSEMBLY BIOSCIENCES INC 2.7%
Value $6.191M Shares 314,410 Est. Cost $28.21 Unrealized
CLOVIS ONCOLOGY INC 2.7%
Value $6.19M Shares 249,389 Est. Cost $23.17 Unrealized
URGN UROGEN PHARMA LTD 2.6%
Value $5.831M Shares 157,862 Est. Cost $41.92 Unrealized 0.0%
ALDX ALDEYRA THERAPEUTICS INC 2.3%
Value $5.267M Shares 583,300 Est. Cost $9.71 Unrealized -12.5%
BMRN BIOMARIN PHARMACEUTICAL INC 2.2%
Value $5.097M Shares 57,384 Est. Cost $91.65 Unrealized +1.1%
EXACT SCIENCES CORP 2.1%
Value $4.721M Shares 54,500 Est. Cost Unrealized
STRONGBRIDGE BIOPHARMA PLC 2.0%
Value $4.651M Shares 933,876 Est. Cost $4.65 Unrealized
WAGEWORKS INC 1.9%
Value $4.377M Shares 115,926 Est. Cost $37.76 Unrealized
NEVRO CORP 1.9%
Value $4.375M Shares 70,000 Est. Cost Unrealized
SIERRA ONCOLOGY INC 1.8%
Value $4.203M Shares 2,457,683 Est. Cost $1.95 Unrealized
CNC CENTENE CORP DEL 1.8%
Value $4.163M Shares 78,400 Est. Cost $60.41 Unrealized +0.5%
MILLENDO THERAPEUTICS INC 1.8%
Value $4.061M Shares 270,762 Est. Cost $8.31 Unrealized
INTEC PHARMA LTD JERUSALEM 1.7%
Value $3.98M Shares 542,919 Est. Cost $4.60 Unrealized
CATALYST BIOSCIENCES INC 1.7%
Value $3.927M Shares 484,200 Est. Cost $9.31 Unrealized
ACIU AC IMMUNE SA 1.6%
Value $3.588M Shares 710,541 Est. Cost $6.36 Unrealized 0.0%
TELIGENT INC NEW 1.5%
Value $3.528M Shares 3,041,568 Est. Cost $3.21 Unrealized
PROVIDENCE SVC CORP 1.5%
Value $3.486M Shares 52,324 Est. Cost $67.28 Unrealized
KURA KURA ONCOLOGY INC 1.3%
Value $2.868M Shares 172,894 Est. Cost $16.20 Unrealized -4.9%
MGNX MACROGENICS INC 0.8%
Value $1.934M Shares 107,560 Est. Cost $19.75 Unrealized -12.5%
MOLECULAR TEMPLATES INC 0.8%
Value $1.73M Shares 297,790 Est. Cost $5.81 Unrealized
MGTX MEIRAGTX HOLDINGS PLC 0.7%
Value $1.573M Shares 91,317 Est. Cost $14.09 Unrealized 0.0%
ALDEYRA THERAPEUTICS INC 0.6%
Value $1.466M Shares 162,300 Est. Cost Unrealized
UROV UROVANT SCIENCES LTD 0.4%
Value $1.004M Shares 99,870 Est. Cost $10.05 Unrealized
CERECOR INC 0.3%
Value $665K Shares 113,835 Est. Cost $3.23 Unrealized
CIDARA THERAPEUTICS INC 0.3%
Value $584K Shares 220,264 Est. Cost $6.80 Unrealized
AQUINOX PHARMACEUTICALS INC 0.0%
Value $76,000 Shares 28,300 Est. Cost $2.50 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 0.0%
Value $68,000 Shares 709 Est. Cost $89.70 Unrealized 0.0%